Drug: TYSABRI Injury: Multiple sclerosis Quarter: 2016Q3
Total Records: 77 Number of Pages: 4
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
118531636 | TYSABRI | Multiple sclerosis | BIOGEN | 60.68 YR | F | 0 | 20160728 | US |
119327174 | TYSABRI | Multiple sclerosis | BIOGEN | 55.07 YR | F | 0 | 20160711 | US |
120128822 | TYSABRI | Multiple sclerosis | BIOGEN | 56.28 YR | F | 0 | 20160829 | US |
120131982 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160808 | US |
120854914 | TYSABRI | Multiple sclerosis | BIOGEN | 37.84 YR | F | 0 | 20160919 | IT |
122329403 | TYSABRI | Multiple sclerosis | BIOGEN | 37.46 YR | F | 85 KG | 20160721 | US |
123097112 | TYSABRI | Multiple sclerosis | BIOGEN | 33.43 YR | F | 50 KG | 20160719 | AT |
123396535 | TYSABRI | Multiple sclerosis | BIOGEN | 40.68 YR | F | 0 | 20160804 | US |
123822933 | TYSABRI | Multiple sclerosis | BIOGEN | 47.45 YR | M | 0 | 20160708 | BR |
123835872 | TYSABRI | Multiple sclerosis | BIOGEN | 61.42 YR | M | 0 | 20160819 | BR |
124336075 | TYSABRI | Multiple sclerosis | BIOGEN | 36.01 YR | M | 92 KG | 20160928 | US |
124478622 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160815 | US |
124575932 | TYSABRI | Multiple sclerosis | BIOGEN | 49.82 YR | M | 0 | 20160715 | US |
124622443 | TYSABRI | Multiple sclerosis | BIOGEN | 46.77 YR | F | 0 | 20160701 | US |
124646144 | TYSABRI | Multiple sclerosis | BIOGEN | 49.13 YR | F | 0 | 20160826 | US |
124820235 | TYSABRI | Multiple sclerosis | BIOGEN | 36.38 YR | F | 0 | 20160728 | US |
124947882 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | M | 68 KG | 20160812 | US |
124983832 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160917 | US |
124997303 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160905 | PT |
125204381 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | M | 0 | 20160701 | US |
Total Records: 77 Number of Pages: 4